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Abstract
Objective—Biological variation consists of within-person (WP) and between- 
person (BP) variation. These components of biological variation are used to set 
analytical goals for imprecision and bias, evaluate serial changes for individual 
analytes, and assess the clinical utility of population-based reference intervals. 
Estimates of WP coefficients of variation (CVw) and BP coefficients of variation 
(CVg) for laboratory analytes were estimated from the 1999-2002 National 
Health and Nutrition Examination Survey (NHANES).
Methods—NHANES is a survey of the noninstitutionalized civilian U.S. 
population that uses a stratified, multistage probability design to collect a 
nationally representative sample. Between- and within-person variations were 
estimated for 34 laboratory analytes, including general biochemical, nutritional, 
and environmental analytes. Between-person variation was estimated taking into 
account the complex sample design of NHANES by Taylor series linearization. 
For W P variation, a nonrandom sample was obtained with an average of 18.8 
days (range: 3-51 days) between two analyte measurements. Data outliers were 
excluded using Tukey’s method to obtain more stable estimates of variation.
Results—The BP and WP variations were estimated on as many as 18,761 
and 853 sample persons, respectively. When compared with the BP sample, the 
WP sample was older (mean age: 39 compared with 30 years) and had more 
non-Hispanic white (45% compared with 37%) and fewer Mexican-American 
(19% compared with 30%) persons. There was no statistically significant 
difference in gender proportions between the BP and WP samples. Serum sodium 
had the lowest CVg (1.8%) and the lowest CVw (1.0%). The index of 
individuality (CVw /CVg) ranged from 0.20 for blood lead to 0.76 for serum iron. 
The CVg exceeded the analytical method coefficient of variation for all analytes. 
Within-person variation was also compared between males and females, and 
several analytes revealed significant differences (p<0.01). Serum ferritin had the 
greatest difference for CVw (males, 17.9% compared with females, 28.8%).
Keywords: within-person differences • between-person differences • laboratory 
tests • survey
Introduction
Laboratory analytes for individuals 
are subject to several sources of 
variation, including biological, 
preanalytical (specimen collection), 
analytical (bias and imprecision), and 
postanalytical variation (reporting of 
results). Laboratory analytical bias is the 
closeness of an analyte result to the 
‘‘true value’’ of the result, and the true 
value of a laboratory result is 
established by a ‘‘gold standard’’ 
method using standard reference 
materials. Bias is a measure of the 
systematic error of laboratory 
measurements. Precision is the 
repeatability of an analyte result if the 
same sample is tested many times, and 
the imprecision of an analyte is a 
measure of random errors. Biological 
variation consists of within-person (WP) 
and between-person (BP) variations, 
which are used to set analytical goals 
for bias and imprecision, assess serial 
changes in individual analytes, and 
gauge the clinical utility of population- 
based reference intervals.
The goals of imprecision and bias 
for a laboratory analyte differ depending 
on its intended use in screening, 
diagnosis, or monitoring the course of 
diseases in patients. For example, the 
WP variation, a component of
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imprecision, should be smaller than BP 
variation when monitoring serial 
changes of laboratory analyte values in 
an individual. Ideally, desirable goals for 
imprecision (I) and bias (B) have been 
related to the WP coefficient of 
variation (CVw) and the BP coefficient 
of variation (CVg) of laboratory analytes 
(1-3). Between-person variation has 
been studied extensively for 
demographic differences including age, 
sex, and, occasionally, race and 
ethnicity. The W P variation has rarely 
been evaluated by demographic 
characteristics.
Imprecision should ideally be less than 
one-half of the CVw , and bias should be 
less than 0.25[(CVw)2 + (CVg)2]1/2 (2). The 
total error of a laboratory measurement 
reflects the underlying bias and imprecision 
of an analyte. The goal for total error 
should be less than kI + B, where k  = 1.65 
at a  = 0.05 (2). Analytical variation 
includes the imprecision and changes in 
bias (for example, changes in method 
calibration), which are usually negligible. 
Hence, the analytical coefficient of 
variation (CVa ) is estimated by the method 
imprecision coefficient of variation (CVi ). 
The total coefficient of variation (CVt ) of a 
laboratory analyte can be estimated 
assuming that all sources of error are 
measured at the same analyte mean and 
that preanalytical and postanalytical sources 
of variation are negligible. The CVt is 
calculated as [(CVa )2 + (CVw )2]1/2 (2).
The WP and BP variations have 
been reported for selected analytes from 
the Third National Health and Nutrition 
Examination Survey (NHANES III) 
conducted from 1988-1994 (4). In the 
present study, BP and W P variations for 
selected laboratory analytes are 
presented for a nationally representative 
sample based on the 1999-2002 
National Health and Nutrition 
Examination Survey (NHANES).




Estimates of CVw and CVg for 
laboratory analytes were calculated from 
the 1999-2002 NHANES (5,6), a 
cross-sectional survey that collected data
on the civilian noninstitutionalized U.S. 
population through questionnaires and 
medical examinations, including 
laboratory analytes. NHANES 1999— 
2002 used a stratified, multistage 
probability design to collect a nationally 
representative sample. Laboratory 
methods for NHANES 1999-2002, 
including imprecision, have been 
described (5,6).
The BP and WP means, standard 
deviations, and coefficients of variation 
(CVs) for 34 general biochemical, 
nutritional, and environmental analytes 
are shown in Table 1. The BP variations 
were estimated on 18,761 sample 
participants from NHANES 1999-2002. 
The WP variations were estimated for a 
convenience sample of 853 individuals 
based on NHANES 2000-2002 data. In 
NHANES 1999-2002, different age 
groups were selected for the various 
analytes and the minimum age was 1 
year (5,6). The WP sample participants 
were recruited for a second analyte 
measurement. The WP participants were 
not selected randomly but recruited 
according to several criteria, including 
approximately equal proportions of 
males and females with an 
approximately uniform age distribution 
of 16-69 years. Participants also were 
recruited to obtain about equal numbers 
of Mexican-American and non-Hispanic 
black and white persons. The target size 
of the WP sample was 5% of those 
participants who had phlebotomy during 
the initial visit to the NHANES mobile 
examination center. The W P participants 
were asked to return for a second 
phlebotomy no sooner than 8 days after 
their initial blood draw. Compared with 
the BP sample, the WP sample was 
older (mean age: 39 compared with 30 
years) and had more non-Hispanic white 
(45% compared with 37%) and fewer 
Mexican-American (19% compared with 
30%) persons. There was no statistically 
significant difference in sex proportions 
when comparing the BP and WP 
samples.
The BP variation was estimated 
taking into account the complex design of 
NHANES by Taylor series linearization 
(7). The BP standard deviation was 
calculated as (SE2 + SDsrs2)1/2, where SE 
is the standard error of the mean obtained
from the complex design and SDsrs2  is the 
square of the standard deviation assuming 
a simple random sample. The WP 
variation was estimated from a 
nonrandom, unweighted sample with a 
mean of 18.8 days (range: 3-51 days) 
between two analyte measurements. The 
CVw was calculated as [(CVt  )2-  
(CVa )2]1/2. The distributions of several 
analytes were nongaussian, and extreme 
outliers were excluded to obtain an 
approximately gaussian distribution with 
more stable estimates of variation. Outliers 
were eliminated by use of Tukey’s 
method, which defines outliers as three 
interquartile ranges below the 25th 
percentile or above the 75th percentile (8). 
Male and female WP variations were 
compared. Ninety-five percent confidence 
intervals were estimated for the CVw 
using software developed by Verrill (9). A 
likelihood ratio test was performed to 
determine if the CVw for males and 
females for a laboratory analyte were 
equal (10). Statistical analyses were 
carried out with SAS for Windows 
software (SAS Institute) and SUDAAN 
software (Research Triangle Institute).
Results and Discussion
The BP and WP means, standard 
deviations, and CVs for 34 laboratory 
analytes are shown in Table 1. The CVw 
and CVg exceeded the laboratory CV i 
for all laboratory analytes. For most 
laboratory analytes, the mean BP and 
WP analyte values were similar despite 
some demographic differences between 
the two groups. Analytical goals for 
imprecision and bias can be judged by 
use of the CVw and CVg . For example, 
the observed serum total calcium 
imprecision of 1.1% was less than the 
precision goal of one-half of CVw 
(2.3%), or 1.15%. The bias for serum 
total calcium should ideally be 
<0.25[(CVw)2 + (CVg)2]1/2, or 
0.25[(0.023)2 + (0.042)2]1/2, or 1.2%.
The total error is estimated as B + 
1.65(I), or 1.2% + 1.65(1.15%), or 
3.1%. Thus, the total-error serum total 
calcium estimated at the BP mean of 
9.47 mg/dL (Table 1) was 0.29 mg/dL 
(9.47 mg/dL multiplied by 0.031). This 
is less than 1.0 mg/dL, the total error 
goal set by the Clinical Laboratory
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SOURCE: CDC/NCHS, National Health and Nutrition Exam ination Survey, 1999-2002 data.
Figure 1. Original serum sodium compared with repeat serum sodium for sample persons
Improvement Amendments (CLIA) of 
1988 (11).
Serum sodium had the lowest BP 
CV (1.8%) and lowest WP CV (1.0%), 
as seen in Figure 1. For NHANES III, 
serum sodium also had the lowest CVg 
(1.6%) and the lowest CVw (1.3%) (4). 
This reflects the narrow homeostatic 
range for sodium that the body 
maintains. High CVw and CVg values 
were seen for several analytes, which 
could result from natural population or
individual variations due to sex, dietary 
intake, diurnal variations, disease, 
outlying analyte values, or relatively low 
analyte values. Serum iron (Figure 2) 
had the highest W P CV (31.9%), 
reflecting its large diurnal variation (12). 
Serum ferritin had the highest BP CV 
(89.8%). The BP and WP variations for 
most analytes were similar to 
corresponding variations seen in 
NHANES III (4).
The ratio of CVw to CVg, also 
known as the index of individuality, is 
important in determining the use of 
population-based reference (normal) 
intervals in detecting changes of disease 
status in individuals (13,14). When the 
index of individuality is low (less than 
0.6), the individual results stay within a 
narrow range compared with the 
population reference interval. Hence, a 
low index suggests the utility of 
evaluating serial changes in analyte 
values in an individual, but population- 
based reference intervals would be of 
limited use. A high index (greater than 
1.4) suggests that the population-based 
reference interval is appropriate when 
interpreting an individual’s laboratory 
anlayte value. The index of individuality 
ranged from 0.20 for blood lead to 0.76 
for serum iron (Table 1).
The BP and WP variations were 
analyzed by sex. The means, standard 
deviations, and CVs for 34 laboratory 
analytes are presented for males 
(Table 2) and females (Table 3). Several 
laboratory analytes had significant 
differences (p<0.01) in the WP CV 
when males and females were 
compared. Females had higher CVw 
than males for blood lead, red blood cell 
folate, serum ferritin, homocysteine, 
methylmalonic acid, albumin, alanine 
aminotransferase, creatinine, gamma 
glutamyl transferase, and potassium. 
Males had higher CVw than females for 
serum lactate dehydrogenase and 
phosphorus. For ferritin (Figure 3), the 
higher CVw for females may have 
resulted from the lower average WP 
ferritin (61 ng/mL for females compared 
with 131 ng/mL for males), with 
approximately the same W P standard 
deviation for males and females. Lower 
ferritin levels in females reflect lower 
body iron storage, and females can have 
more variable ferritin due to blood loss 
during menstruation or increased iron 
utilization during pregnancy. Borel et al. 
also noted greater WP variation for 
ferritin among females compared with 
males (15). Feinleib et al. noted that 
increased WP variances could lead to 
overestimates of the prevalence of 
disease (16). The WP variance alters the 
BP distribution of analyte values if they 
are based on a single measurement.
Original serum iron ( /jg/dL)
SOURCE: CDC/NCHS, National Health and Nutrition Exam ination Survey, 1999-2002  data.
Figure 2. Original serum iron compared with repat serum iron for sample persons
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Figure 3. Original seum ferritin compared with repeat serum ferritin for males and females
0
0
Increased WP variance makes the BP 
distribution flatter and wider. This 
results in more people being above or 
below a cutoff value than distributions 
based on only single measurements from 
subjects.
In this study, BP and W P estimates 
of CVs were obtained for general 
biochemical, nutritional, and 
environmental analytes. NHANES 
1999-2002 provides a better estimate of 
BP variation than other locally 
representative studies because the 
NHANES sample was nationally 
representative (1,17,18). The WP 
variation estimate was limited by the 
nonrandom, self-selected design and
reflected a mean of 19 days between 
two measurements. In addition, the WP 
and BP CVs in NHANES were based on 
a relatively healthy sample of the 
population. The CVw and CVg would be 
increased in a sample of unhealthy 
individuals, as seen in a hospital 
population. The BP sample contained 
participants aged 1 year and over, 
whereas the WP sample was restricted 
to those aged 16-69. The estimate of 
CVw could be improved by use of a 
stratified, multistage probability design 
over different time periods. Differences 
for CVw and CVg among subpopulations 
(sex, age, and race and ethnicity) can be 
further investigated using NHANES
data. Additional W P and BP variation 
data for other laboratory analytes based 
on NHANES 1999-2002 will be 
available in the future.
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Table 1. Between-person (CVg), within-person (CVw), and method (CVa) coefficients of variation and index of individuality (CVw/CVg)
Analyte (units)
Between-person Within-person Method1 Index2
n3 Mean SD CVg  (%) n Mean SD )(%
>sC CVa  (%) CVw /CVg
Albumin (g/dL).................................................... ...........  13,082 4.39 0.33 7.5 831 4.27 0.16 3.5 1.3 0.46
Alkaline phosphatase (U /L).............................. ...........  12,287 77.6 30.0 38.7 828 77.4 6.5 8.1 2.1 0.21
Alanine aminotransferase (U /L ) ...................... ...........  12,728 22.4 9.7 43.4 796 22.4 4.6 20.3 4.0 0.47
Aspartate aminotransferase (U /L )................... ...........  12,757 22.7 6.2 27.1 795 22.3 3.5 15.5 3.1 0.57
Bicarbonate (m m o l/L )....................................... ...........  13,116 23.7 2.3 9.7 835 23.5 1.5 5.1 3.9 0.53
Bilirubin, total (m g/dL)....................................... ...........  12,974 0.65 0.26 39.1 798 0.63 0.13 19.6 6.0 0.50
Blood urea nitrogen (m g/dL)............................ ...........  12,968 13.4 4.3 32.4 822 12.7 2.3 17.9 2.7 0.55
Calcium, total (m g/dL)....................................... ...........  13,109 9.47 0.40 4.2 835 9.45 0.24 2.3 1.1 0.55
Chloride (mmol/L)............................................... ...........  13,088 102.6 2.8 2.8 832 102.6 1.8 1.6 0.8 0.57
Cholesterol, t otal (m g/dL)................................. ...........  13,108 193.6 40.8 21.1 835 192.1 13.5 6.9 1.5 0.33
Creatinine (m g/dL)............................................ ...........  13,011 0.79 0.22 27.6 823 0.80 0.06 6.7 4.6 0.24
Ferritin (ng/m L).................................................. ...........  15,992 83.9 75.3 89.8 796 94.1 20.8 21.8 3.2 0.24
Folate, red blood cell (ng/mL R B C )................ ...........  15,907 292.8 104.7 35.8 835 286.3 28.5 9.1 3.9 0.26
Folate, serum (ng/mL)....................................... ...........  15,750 14.85 7.23 48.7 827 13.16 2.92 21.5 5.4 0.44
Gamma tocopherol (pg/dL).............................. ...........  14,645 226.03 115.32 51.0 265 236.04 55.35 23.2 3.4 0.45
Gamma glutamyl transferase (U /L )................ ...........  12,558 22.7 12.9 56.7 797 23.6 3.9 16.2 3.0 0.29
Glucose (m g /d L )............................................... ...........  12,552 89.1 10.5 11.7 789 88.9 6.8 7.5 1.5 0.64
Homocysteine (p m o l/L ).................................... ...........  15,880 7.508 2.786 37.1 832 7.641 0.982 12.2 4.0 0.33
Iron (p g /d L )....................................................... ...........  16,663 88.1 36.9 41.9 299 86.4 27.7 31.9 3.8 0.76
Lactate dehydrogenase (U /L ) ......................... ...........  13,070 139.9 29.8 21.3 831 135.4 12.6 8.9 2.7 0.42
Lead, blood (p g /d L )......................................... ...........  16,521 1.82 1.17 64.4 833 1.69 0.23 12.6 4.3 0.20
Methylmalonic acid (pm ol/L )............................ ...........  15,675 0.137 0.056 41.0 822 0.125 0.025 18.7 7.4 0.46
Phosphorus (m g/dL)......................................... ...........  13,115 3.68 0.60 16.4 833 3.72 0.36 9.5 1.7 0.58
Potassium (m m ol/L )......................................... ...........  13,109 4.09 0.33 8.1 834 4.06 0.23 5.5 1.5 0.68
Protein, total (g/dL)............................................ ...........  13,108 7.42 0.46 6.2 833 7.37 0.26 3.3 1.3 0.53
Protoporphyrin (pg/dL R B C )............................ ...........  16,592 49.6 16.3 32.9 300 51.0 5.4 9.8 4.1 0.30
Sodium (m m ol/L)............................................... ...........  13,105 139.1 2.5 1.8 834 138.6 1.7 1.0 0.8 0.55
Total iron binding capacity (p g /d L )................ ...........  16,588 370.6 59.7 16.1 294 373.1 37.0 9.0 4.2 0.56
Triglycerides (mg/dL)......................................... ...........  12,849 125.1 71.0 56.8 814 126.3 35.2 27.8 1.9 0.49
Uric acid (m g/dL)............................................... ...........  13,115 5.33 1.46 27.4 835 5.35 0.50 9.3 1.2 0.34
Vitamin A (pg/dL)............................................... ...........  15,784 56.05 17.37 31.0 297 55.38 6.03 10.4 3.3 0.33
Vitamin B ^  (pg /m L)......................................... ...........  15,736 527.4 229.8 43.6 831 497.9 74.3 14.6 2.9 0.34
Vitamin D, 25-hydroxy (ng/mL)......................... ...........  7,802 23.8 9.0 37.9 460 21.2 3.0 11.3 8.2 0.30
Vitamin E (pg/dL)............................................... ...........  15,454 1,132.79 451.14 39.8 285 1,162.99 163.94 13.9 2.5 0.35
1Method analytical CV is the laboratory method precision assum ing no method bias exists.
2Index of individuality.
3Between-person sample s ize fo r each laboratory test varied by age of participant and response rate fo r the test. 
NOTE: CV is coefficient of variation, n is the  s ize of the  subsample, and SD is standard deviation.
imprecision, bias and total error 
(desirable and minimum): The 2004 
update. Available from: http:// 
www.westgard.com/guest26.htm. 
Accessed September 10, 2009.
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Table 2. Between-person (CVg), within-person (CVw), and method (CVa) coefficients of variation for males
Analyte (units)
Between-person Within-person Method1
n2 Mean SD CVg  (%) n Mean SD CVw  (%) CVa  (%)
Albumin (g/dL).................................................... ...........  6,313 4.50 0.31 6.9 406 4.41 0.15 t3.22 1.3
Alkaline phosphatase (U /L).............................. ...........  5,651 80.6 31.0 38.4 406 79.9 6.7 8.1 2.1
Alanine aminotransferase (U /L ) ...................... ...........  6,035 25.8 10.2 39.6 380 26.1 4.9 tt1 8 .2 4.0
Aspartate aminotransferase (U /L )................... ...........  6,083 24.5 6.3 25.6 376 24.4 4.0 16.0 3.1
Bicarbonate (m m o l/L )....................................... ...........  6,321 24.1 2.2 9.3 408 24.0 1.6 5.3 3.9
Bilirubin, total (m g/dL)....................................... ...........  6,206 0.73 0.27 36.7 381 0.71 0.15 20.0 6.0
Blood urea nitrogen (m g/dL)............................ ...........  6,245 14.3 4.3 29.8 399 13.8 2.5 18.2 2.7
Calcium, total (m g/dL)....................................... ...........  6,315 9.52 0.38 4.0 408 9.52 0.23 2.2 1.1
Chloride (mmol/L)............................................... ...........  6,308 102.4 2.8 2.8 406 102.4 1.8 1.6 0.8
Cholesterol, total (m g/dL)................................. ...........  6,314 192.0 41.2 21.5 408 187.3 13.0 6.8 1.5
Creatinine (m g/dL)............................................ ...........  6,246 0.89 0.20 22.4 399 0.93 0.07 tt5 .6 4.6
Ferritin (ng/m L).................................................. ...........  7,624 112.3 82.8 73.7 373 130.9 23.8 tt1 7 .9 3.2
Folate, red blood cell (ng/mL R B C )................ ...........  7,748 283.7 98.3 34.6 404 268.6 24.1 tt8 .1 3.9
Folate, serum (ng/mL)....................................... ...........  7,686 14.13 6.74 47.7 405 12.42 2.61 20.3 5.4
Gamma tocopherol (pg/dL).............................. ...........  7,118 226.60 114.39 50.5 119 239.92 60.55 25.0 3.4
Gamma glutamyl transferase (U /L )................ ...........  5,944 26.3 13.5 51.2 382 28.0 4.3 t15.0 3.0
Glucose (m g /d L )............................................... ...........  6,017 90.7 10.2 11.3 380 91.0 6.6 7.1 1.5
Homocysteine (p m o l/L ).................................... ...........  7,698 8.035 2.805 34.9 400 8.440 0.971 tt1 0 .8 4.0
Iron (p g /d L )....................................................... ...........  8,144 93.9 37.0 39.4 136 94.5 30.0 31.5 3.8
Lactate dehydrogenase (U /L ) ......................... ...........  6,286 141.3 29.9 21.1 405 136.6 13.5 t9.5 2.7
Lead, blood (p g /d L )......................................... ...........  7,970 2.13 1.25 58.7 396 1.96 0.23 t t1 1 .00 4.3
Methylmalonic acid (pm ol/L )............................ ...........  7,598 0.140 0.056 39.7 396 0.129 0.024 t17.3 7.4
Phosphorus (m g/dL)......................................... ...........  6,319 3.65 0.64 17.7 408 3.68 0.38 t10.3 1.7
Potassium (m m ol/L )......................................... ...........  6,315 4.15 0.33 7.9 408 4.12 0.22 t5.1 1.5
Protein, total (g/dL)............................................ ...........  6,313 7.48 0.44 5.9 408 7.46 0.25 3.1 1.3
Protoporphyrin (pg/dL R B C )............................ ...........  8,182 45.2 14.0 30.8 137 45.2 5.2 10.7 4.1
Sodium (m m ol/L)............................................... ...........  6,315 139.4 2.4 1.7 407 139.1 1.7 1.0 0.8
Total iron binding capacity (p g /d L )................ ...........  8,117 361.6 54.3 15.0 133 358.2 35.9 9.1 4.2
Triglycerides (mg/dL)......................................... ...........  6,140 131.4 74.8 56.9 395 133.0 38.6 28.9 1.9
Uric acid (m g/dL)............................................... ...........  6,318 6.04 1.30 21.5 408 6.20 0.55 8.7 1.2
Vitamin A (pg/dL)............................................... ...........  7,679 58.85 17.39 29.5 135 59.11 6.55 10.6 3.3
Vitamin B1 2  (pg /m L)......................................... ...........  7,676 525.1 217.8 41.5 404 507.0 73.3 14.2 2.9
Vitamin D, 25-hydroxy (ng/mL)......................... ...........  3,781 24.2 8.5 34.9 212 21.7 3.1 11.6 8.2
Vitamin E (pg/dL)............................................... ...........  7,548 1,111.43 442.23 39.8 128 1,128.07 145.51 12.7 2.5
t  p  <  0.01 for likelihood ratio of CVW fo r males equivalent to  CVW fo r females. 
f t  p  <  0.001 fo r likelihood ratio of CVw fo r males equ iva lent to  CVw fo r females.
''M ethod analytical CV is the laboratory method precision assum ing no method bias exists.
2Between-person sample s ize fo r each laboratory test varied by age of participant and response rate fo r the test. 
NOTE: CV is coefficient of variation, n is the  s ize of the  subsample, and SD is standard deviation.
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Table 3. Between-person (CVg), within-person (CVW), and method (CVa) coefficients of variation for females
Analyte (units)
Between-person Within-person Method1
n2 Mean SD CVg  (%) n Mean SD )(%
>sC CVa  (%)
Albumin (g/dL).................................................... ...........  6,769 4.29 0.32 7.4 425 4.14 0.16 3.7 1.3
Alkaline phosphatase (U /L).............................. ...........  6,636 74.8 28.8 38.5 422 75.0 6.3 8.1 2.1
Alanine aminotransferase (U /L ) ...................... ...........  6,693 19.2 8.0 41.8 416 19.0 4.4 22.9 4.0
Aspartate aminotransferase (U /L )................... ...........  6,674 21.1 5.6 26.5 419 20.4 3.1 14.8 3.1
Bicarbonate (m m ol/L )....................................... ...........  6,795 23.2 2.3 9.7 427 22.9 1.4 4.9 3.9
Bilirubin, total (m g/dL)....................................... ...........  6,768 0.59 0.22 38.1 417 0.56 0.11 18.5 6.0
Blood urea nitrogen (m g/dL)............................ ...........  6,723 12.5 4.2 33.8 423 11.58 2.04 17.4 2.7
Calcium, total (m g/dL)....................................... ...........  6,794 9.41 0.40 4.3 427 9.39 0.25 2.4 1.1
Chloride (mmol/L)............................................... ...........  6,780 102.8 2.8 2.7 426 102.73 1.81 1.6 0.8
Cholesterol, total (m g/dL)................................. ...........  6,794 195.2 40.3 20.6 427 196.58 13.91 6.9 1.5
Creatinine (m g/dL)............................................ ...........  6,765 0.69 0.19 26.8 424 0.68 0.06 8.1 4.6
Ferritin (ng/m L).................................................. ...........  8,368 58.4 56.9 97.5 423 61.1 17.7 28.8 3.2
Folate, red blood cell (ng/mL R B C )................ ...........  8,159 301.5 109.9 36.4 431 302.9 32.1 9.8 3.9
Folate, serum (ng/mL)....................................... ...........  8,064 15.54 7.60 48.9 422 13.86 3.20 22.4 5.4
Gamma tocopherol (pg/dL).............................. ...........  7,527 225.49 116.20 51.5 146 232.60 50.72 21.5 3.4
Gamma glutamyl transferase (U /L )................ ...........  6,614 19.5 11.4 58.4 415 19.5 3.5 17.5 3.0
Glucose (m g /d L )............................................... ...........  6,535 87.6 10.4 11.9 409 87.1 6.9 7.8 1.5
Homocysteine (p m o l/L ).................................... ...........  8,182 7.009 2.675 38.2 432 6.897 0.993 13.8 4.0
Iron (p g /d L )....................................................... ...........  8,519 82.6 36.0 43.6 163 79.3 25.7 32.1 3.8
Lactate dehydrogenase (U /L ) ......................... ...........  6,784 138.5 29.7 21.4 426 134.2 11.6 8.2 2.7
Lead, blood (p g /d L )......................................... ...........  8,551 1.53 1.01 66.1 437 1.45 0.22 14.5 4.3
Methylmalonic acid (pm ol/L )............................ ...........  8,077 0.133 0.056 42.1 426 0.122 0.026 20.0 7.4
Phosphorus (m g/dL)......................................... ...........  6,796 3.71 0.56 15.2 425 3.75 0.34 8.8 1.7
Potassium (m m ol/L )......................................... ...........  6,794 4.04 0.33 8.1 426 4.00 0.24 5.9 1.5
Protein, total (g/dL)............................................ ...........  6,795 7.37 0.47 6.4 425 7.29 0.27 3.4 1.3
Protoporphyrin (pg/dL R B C )............................ ...........  8,410 53.8 17.3 32.1 163 56.2 5.6 9.1 4.1
Sodium (m m ol/L)............................................... ...........  6,790 138.8 2.5 1.8 427 138.2 1.7 1.0 0.8
Total iron binding capacity (p g /d L )................ ...........  8,471 379.2 63.2 16.7 161 386.3 37.9 8.9 4.2
Triglycerides (mg/dL)......................................... ...........  6,709 119.3 66.9 56.1 419 119.9 31.7 26.4 1.9
Uric acid (m g/dL)............................................... ...........  6,797 4.66 1.28 27.5 427 4.55 0.45 9.9 1.2
Vitamin A (pg/dL)............................................... ...........  8,105 53.38 16.93 31.7 162 52.05 5.56 10.2 3.3
Vitamin B1 2  (pg /m L)......................................... ...........  8,060 529.6 240.7 45.5 427 489.4 75.2 15.1 2.9
Vitamin D, 25-hydroxy (ng/mL)......................... ...........  4,021 23.4 9.5 40.6 248 20.7 2.8 11.0 8.2
Vitamin E (pg/dL)............................................... ...........  7,906 1,153.34 458.66 39.8 157 1,194.11 177.55 14.7 2.5
1Method analytical CV is the laboratory method precision assum ing no method bias exists.
2Between-person sample s ize fo r each laboratory test varied by age of participant and response rate fo r the test. 
NOTE: CV is coefficient of variation, n is the  s ize of the  subsample, and SD is standard deviation.
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